Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole.

Gillen D, Wirz AA, Neithercut WD, Ardill JE, McColl KE.

Gut. 1999 Apr;44(4):468-75.

2.

Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status.

Gillen D, Wirz AA, Ardill JE, McColl KE.

Gastroenterology. 1999 Feb;116(2):239-47.

PMID:
9922302
3.

Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole.

Verdú EF, Armstrong D, Idström JP, Labenz J, Stolte M, Dorta G, Börsch G, Blum AL.

Gut. 1995 Dec;37(6):743-8.

4.

The effect of ammonia on omeprazole-induced reduction of gastric acidity in subjects with Helicobacter pylori infection.

Bercík P, Verdú EF, Armstrong D, Idström JP, Cederberg C, Markert M, Crabtree JE, Stolte M, Blum AL.

Am J Gastroenterol. 2000 Apr;95(4):947-55.

PMID:
10763943
5.

Effects of pumaprazole (BY841), a novel reversible proton pump antagonist, and of omeprazole, on intragastric acidity before and after cure of Helicobacter pylori infection.

Martínek J, Blum AL, Stolte M, Hartmann M, Verdú EF, Lühmann R, Dorta G, Wiesel P.

Aliment Pharmacol Ther. 1999 Jan;13(1):27-34.

6.

Helicobacter pylori eradication releases prolonged increased acid secretion following omeprazole treatment.

Gillen D, Wirz AA, McColl KE.

Gastroenterology. 2004 Apr;126(4):980-8. Erratum in: Gastroenterology. 2004 Aug;127(2):694.

PMID:
15057737
7.

Pathophysiology of gastric acid secretion in patients with chronic renal failure: influence of Helicobacter pylori infection.

Watanabe H, Hiraishi H, Ishida M, Kazama JJ, Terano A.

J Intern Med. 2003 Nov;254(5):439-46.

8.

Acid inhibitory potency of twice a day omeprazole is not affected by eradication of Helicobacter pylori in healthy volunteers.

Thomson AB, Keelan M, Lastiwka R, Appelman-Eszcuck S, Zuk L, Drozdowski L, Prentice A, Sinclair P.

Helicobacter. 2003 Feb;8(1):46-58.

PMID:
12603616
9.

Effect of enprostil on omeprazole-induced hypergastrinemia and inhibition of gastric acid secretion in peptic ulcer patients.

Tari A, Hamada M, Kamiyasu T, Sumii K, Haruma K, Inoue M, Kishimoto S, Kajiyama G, Walsh JH.

Dig Dis Sci. 1997 Aug;42(8):1741-6.

PMID:
9286243
10.

Omeprazole, Helicobacter pylori status, and alterations in the intragastric milieu facilitating bacterial N-nitrosation.

Mowat C, Williams C, Gillen D, Hossack M, Gilmour D, Carswell A, Wirz A, Preston T, McColl KE.

Gastroenterology. 2000 Aug;119(2):339-47.

PMID:
10930369
11.

Inhibitory potency of twice-a-day omeprazole on gastric acidity is enhanced by eradication of H. pylori in duodenal ulcer patients.

Thomson AB, Keelan M, Lastiwka R, Appelman-Eszczuk S, Zuk L, Drozdowski L, Prentice A, Sinclair P.

Dig Dis Sci. 2003 Oct;48(10):2045-56.

PMID:
14627354
12.
13.

Influence of H. pylori infection on meal-stimulated gastric acid secretion and gastroesophageal acid reflux.

Feldman M, Cryer B, Sammer D, Lee E, Spechler SJ.

Am J Physiol. 1999 Dec;277(6 Pt 1):G1159-64.

16.
17.

Intragastric nitric oxide/nitrite in Helicobacter pylori-infected subjects.

Fändriks L, von Bothmer C, Aneman A, Olbe L, Pettersson A.

Scand J Gastroenterol. 2001 Apr;36(4):347-50.

PMID:
11336156
18.

Is the sensitivity to gastric acid inhibition Helicobacter pylori status-dependent?

Smout AJ.

Scand J Gastroenterol Suppl. 1998;225:32-5. Review.

PMID:
9515750
19.

Eradication of Helicobacter pylori increases nocturnal intragastric acidity during dosing with rabeprazole, omeprazole, lansoprazole and placebo.

Williams MP, Usselmann B, Chilton A, Sercombe J, Nwokolo CU, Pounder RE.

Aliment Pharmacol Ther. 2003 Mar 15;17(6):775-83.

20.

Acid-inhibitory effects of omeprazole and lansoprazole in Helicobacter pylori-negative healthy subjects.

Geus WP, Mulder PG, Nicolai JJ, Van den Boomgaard DM, Lamers CB.

Aliment Pharmacol Ther. 1998 Apr;12(4):329-35.

Items per page

Supplemental Content

Write to the Help Desk